课题基金 / 基金详情

LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS

LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
NKR P1 的配体——自然杀伤细胞上的受体
批准号:
2732785
负责人:
Mary C Nakamura
金额:
$8.91万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 2000-06-30

项目摘要

项目成果

Mary C Nakamura的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural killer (NK) cells are able to specifically recognize and lyse certain tumor or virally-infected cells without prior sensitization to targets. The cell surface molecules responsible for the specificity of the NK-target cell interaction are not defined. Recent structural and functional evidence suggests that the cell surface glycoprotein NKR-P1 on rat NK cells may serve as an important receptor in the recognition of target cells. The identification of ligands on target cells which bind to NKR-P1 will help to define the mechanisms underlying the NK cell response. NKR-P1 is a type II integral membrane protein with an extracellular C-type lectin domain. The lectin region is structurally similar to known receptor molecules. Our laboratory has generated a mutant rat NK cell line (derived from RNK- 16) lacking expression of NKR-P1, which is selectively unable to lyse certain target cells derived from C57BL/6 (H-2b) mice. Other target cell lines are killed equally by mutant and wild type RNK-16 cells. These results support the hypothesis that NKR-P1 may be required for recognition and/or lysis of some but not all target cells. My proposed studies will focus on defining the ligand(s) for NKR-P1 on target cells. I have prepared a recombinant soluble chimeric protein composed of the extracellular domain of NKR-P1 fused to the Fc portion of human IgG1 (rNKR-P1/Fc). Utilizing this chimeric protein as a probe for ligand, target cells will be screened by FACS, by cell binding to immobilized chimeric protein, and by antibody-dependent cell mediated cytotoxicity. To demonstrate that target cell interactions with soluble chimeric rNKR-P1/Fc are analogous to cell surface protein interactions, CHO cells, transfected to express high levels of cell surface NKR-P1, will be used to examine specific cell-cell adhesion to targets. Ligand(s) for NKR-P1 will be affinity-purified from appropriate target cells using immobilized rNKR-P1/Fc. Putative ligand(s) will be characterized with regard to size, susceptibility to proteolysis, carbohydrate content, and relation to known cell-surface molecules. These studies will identify ligand(s) for NKR-P1, a proposed receptor on NK cells. Identification of the molecules involved in the specificity of NK-target cell recognition will provide important insight into the role of NK cells in immune regulation and how they might discriminate between tumors and non-neoplastic cells.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s40104-020-00536-0
发表时间: 2021-01-11
期刊: Journal of animal science and biotechnology
影响因子: 7
作者: [Wang J, Lyu W, Zhang W, Chen Y, Luo F, Wang Y, Ji H, Zhang G]
通讯作者: Zhang G
The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
H-2Dd 的 alpha2 结构域限制了鼠 NK 细胞抑制性受体 Ly-49A 的等位基因特异性。
DOI: --
发表时间: 1998
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Sundback,J, Nakamura,MC, Waldenstrom,M, Niemi,EC, Seaman,WE, Ryan,JC, Karre,K]
通讯作者: Karre,K
Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population.
环磷酰胺和 IL-12 治疗后大肉瘤的免疫排斥需要 NK 和 NK T 细胞,并且与新的 NK T 细胞群的诱导有关。
DOI: 10.4049/jimmunol.167.5.2569
发表时间: 2001
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Karnbach,C, Daws,MR, Niemi,EC, Nakamura,MC]
通讯作者: Nakamura,MC
MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
表达腺病毒 E1A 的肿瘤细胞上的 MHC I 类分子抑制 NK 细胞杀伤,但不抑制 NK 细胞介导的肿瘤排斥。
DOI: 10.1093/intimm/13.10.1301
发表时间: 2001
期刊: International immunology
影响因子: 4.4
作者: [Routes,JM, Ryan,JC, Ryan,S, Nakamura,M]
通讯作者: Nakamura,M
6
    RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
    Administrative Core
    Administrative Core
    RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY